High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-κB activation

Nature Medicine

Volumn 6, Issue 5, 2000, Pages 573-577

  Lavon, Iris ^a   Goldberg, Iris ^b   Amit, Sharon ^a   Landsman, Limor ^a   Jung, Steffen ^a   Tsuberi, Ben Zion ^a   Barshack, Iris ^b   Kopolovic, Juri ^b   Galun, Eitan ^c   Bujard, Hermann ^d   Ben Neriah, Yinon ^a  

^a HEBREW UNIVERSITY   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; IMMUNOHISTOCHEMISTRY; INFECTION SENSITIVITY; INFLAMMATORY CELL; LISTERIA MONOCYTOGENES; LIVER CELL; LIVER FAILURE; LYMPHOCYTE; MOUSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; SEPSIS; TISSUE SPECIFICITY; TRANSGENE;

ANIMALS; DIAGNOSTIC IMAGING; DISEASE SUSCEPTIBILITY; GENE EXPRESSION REGULATION; I-KAPPA B PROTEINS; IMAGE PROCESSING, COMPUTER-ASSISTED; LISTERIA INFECTIONS; LIVER; LUCIFERASES; LUMINESCENT MEASUREMENTS; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; NF-KAPPA B; RECOMBINANT FUSION PROTEINS; TISSUE DISTRIBUTION;

ANIMALIA; BACTERIA (MICROORGANISMS); LISTERIA MONOCYTOGENES;

EID: 17144449583     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/75057     Document Type: Article

References (25)

1. Barnes, P.J. & Karin, M. Nuclear factor-κB - A pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336, 1066-1071 (1997).
2. Wang, C.Y., Cusack, J.C., Jr., Liu, R. & Baldwin, A.S., Jr. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB. Nature Med. 5, 412-417 (1999).
3. Beg, A.A., Sha, W.C., Bronson, R.T., Ghosh, S. & Baltimore, D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376, 167-169 (1995).
4. Li, Z.-W. et al. The IKKβ subunit ofz IκB kinase (IKK) is essential for NF-κB activation and prevention of apoptosis. J. Exp. Med. 189, 1-7 (1999).
5. Li, Q., Van Antwerp, D., Mercurio, F., Lee, K.-F. & Verma, I.M Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science 284, 321-325 (1999).
6. Tanaka, M. et al. Embryonic lethality, liver degeneration, and impaired NF-κB activation in IKK - deficient mice. Immunity 10, 421-429 (1999).
7. Karin, M. & Ben-Neriah, Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Ann. Rev. Immunol. 18, 621-663 (2000).
8. Kistner, A. et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc. Natl. Acad. Sci. USA 93, 10933-10938 (1996).
9. Attar, R.M. et al. Genetic approaches to study Rel/NFκB/I κB function in mice. Semin. Cancer Biol. 8, 93-101 (1997).
10. Brown, K., Gerstberger, S., Carlson, L., Franzoso, G. & Siebenlist, U. Control of IκBα. proteolysis by site-specific, signal-induced phosphorylation. Science 267, 1485-1491 (1995).
11. Bellas, R.E., FitzGerald, M.J., Fausto, N. & Sonenshein, G.E. Inhibition of NF-κB activity induces apoptosis in murine hepatocytes. Am. J. Pathol. 151, 891-896 (1997).
12. Iimuro, Y. et al. NFκB prevents apoptosis and liver dysfunction during liver regeneration. J. Clin. Invest. 101, 802-811 (1998).
13. Bradham, C.A., Plumpe, J., Manns, M.P., Brenner, D.A. & Trautwein, C. Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am. J. Physiol 275, G387-92 (1998).
14. Taub, R. Blocking NF-κB in the liver: the good and bad news. Hepatology 27, 1445-1446 (1998).
15. Contag, C.H. et al. Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem. Photobiol. 66, 523-531 (1997).
16. Tiegs, G., Hentschel, J. & Wendel, A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90, 196-203 (1992).
17. Mizuhara, H. et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J. Exp. Med. 179, 1529-1537 (1994).
18. Kaufmann, S.H. Immunity to intracellular bacteria. Annu. Rev. Immunol. 11, 129-163 (1993).
19. Armstrong, D. in Principles and Practice of Infectious Diseases (eds. Mandell, G.L., Bennett, J.E. & Dolin R.) 1880-1885 (Churchill Livingstone, New York, 1995).
20. Pfeffer, K. et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73, 457-467 (1993).
21. Endres, R. et al. Listeriosis in p47(phox-/-) and TRp55-/-mice: protection despite absence of ROI and susceptibility despite presence of RNI. Immunity 7, 419-432 (1997).
22. Rogers, H.W., Callery, M.P., Deck, B. & Unanue, E.R. Listeria monocytogenes induces apoptosis of infected hepatocytes. J. Immunol. 156, 679-684 (1996).
23. Conlan, J.W. & North, R.J. Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody. J. Exp. Med. 179, 259-268 (1994).
24. Talbot, D., Descombes, P. & Schibler, U. The 5′ flanking region of the rat LAP (C/EBP β) gene can direct high-level, position-independent, copy number-dependent expression in multiple tissues in transgenic mice. Nucleic Acids Res 22, 756-766 (1994).
25. Gossen, M. et al. Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766-1769 (1995).